Moniek Maarse

COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy”

Huijboom, M., Maarse, M., Aarnink, E., van Dijk, V., Swaans, M., van der Heijden, J., IJsselmuiden, S., Folkeringa, R., Blaauw, Y., Elvan, A., Stevenhagen, J., Vlachojannis, G., van der Voort, P., Westra, S., Chaldoupi, M., Khan, M., de Groot, J., van der Kley, F., van Mieghem, N., van Dijk, E., & 3 othersDijkgraaf, M., Tijssen, J. & Boersma, L., 1 Aug 2022, In: American heart journal. 250, p. 45-56 12 p.

Research output: Contribution to Journal › Article › Academic › peer-review

Hemostatic biomarkers and antithrombotic strategy in percutaneous left atrial interventions: State-of-the-art review

Aarnink, E. W., Huijboom, M. F. M., Bor, W. L., Maarse, M., Zheng, K. L., ten Cate, H., ten Berg, J. M. & Boersma, L. V. A., 1 Jul 2022, In: Thrombosis research. 215, p. 41-51 11 p.

Research output: Contribution to Journal › Review article › Academic › peer-review

Electrocardiogram-based mortality prediction in patients with COVID-19 using machine learning

the CAPACITY-COVID collaborative consortium, Jun 2022, In: Netherlands Heart Journal. 30, 6, p. 312-318 7 p.